CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018

From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/mu L, and CD4 count at ART prescription increased from 160 to 364 c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2021-10, Vol.73 (7), p.E2334-E2337
Hauptverfasser:	Lee, Jennifer S., Humes, Elizabeth A., Hogan, Brenna C., Buchacz, Kate, Eron, Joseph J., Gill, M. John, Sterling, Timothy R., Rebeiro, Peter F., Lima, Viviane Dias, Mayor, Angel, Silverberg, Michael J., Horberg, Michael A., Moore, Richard D., Althoff, Keri N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-HIV Agents - therapeutic use Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count HIV HIV Infections - drug therapy HIV Infections - epidemiology Humans Immunology Infectious Diseases Life Sciences & Biomedicine Microbiology Online Only Prescriptions Science & Technology United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/mu L, and CD4 count at ART prescription increased from 160 to 364 cells/mu L.
ISSN:	1058-4838 1537-6591 1537-6591
DOI:	10.1093/cid/ciaa1904